KPTSF (KP Tissue) Risk Assessment


KPTSF KP Tissue Inc KPTSF
28 GF Score
Price $9.30
! 6 Warning Signs
View Full Analysis

What is KP Tissue Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of KP Tissue is: No Data: Cannot be evaluated.

KP Tissue  (OTCPK:KPTSF) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

KP Tissue Risk Assessment Related Terms

KPTSF vs PG, CL, KVUE: Risk Assessment Comparison

For the Household & Personal Products subindustry, KP Tissue's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

KP Tissue Risk Assessment vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, KP Tissue's Risk Assessment distribution charts can be found below:

* The bar in red indicates where KP Tissue's Risk Assessment falls into.


KPTSF
28GF Score
KP Tissue Inc KPTSF
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KP Tissue Business Description

Other Exchanges KP8:GermanyKPT:Canada
Address 2 Prologis Boulevard, Suite 500, Mississauga, ON, CAN, L5W 0G8
KP Tissue Inc is a holding company. Through its equity holdings in Kruger Products Inc. (the operating company), it is involved in the business of producing, distributing, marketing, and selling various disposable tissue products, including bathroom tissue, facial tissue, paper towels, and napkins for both the consumer and away-from-home markets in North America. The products are marketed under several trademarks, such as Cashmere, Purex, SpongeTowels, Esteem, White Swan, Embassy, and others. A majority of its revenue is generated from the sale of tissue products in the consumer market. Geographically, the company derives maximum revenue from Canada and the rest from the United States.
28GF Score

Get the complete analysis for KPTSF

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.30
Price